Cordant Inc’s Tenet Healthcare THC Stock Holding History

Cordant Inc’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29	Closed	-$2K	–	1132
2022 Q1	$2K	Buy	+29	New	+$2.38K	﹤0.01%	772

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cordant Inc's THC Position: Q2 2022 in Review

Cordant Inc sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 29 shares — an estimated $2K sold.

Cordant Inc first reported a position in THC in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 373 funds tracked by Wall St. Rank hold THC as of Q2 2022.

Cordant Inc reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 29 Tenet Healthcare shares in Q2 2022, an estimated $2K.
Cordant Inc first reported a position in Tenet Healthcare in Q1 2022 and held it in 1 quarter.
Cordant Inc's Tenet Healthcare position peaked at $2K in Q1 2022.
373 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.